Company Financial Health Rules Out Before It Ever Picks
Company financial health tells you what to drop, not what to buy. Why the balance sheet screens fast and selects slowly, and what that changes about order.
See a sample reportThis is a method, not a recommendation. Nothing here, or anywhere else on Taufolio, is investment advice. Treat every example as a starting point for your own research.
A healthy balance sheet is not the reason a share price rises. It is the reason the company is still there on the day it could rise. Company financial health answers whether a business survives, not whether it grows, and most of the disappointment in this area comes from treating those as one question.
The question people actually arrive with sounds different: the company has little debt and a pile of cash, so are the shares going up? The answer is short and mildly annoying. Fundamentals screen fast and cheaply, and they select slowly, so before you screen anything you have to be able to read the side of the sheet where the debt sits, with the date it falls due.
Two questions we keep merging into one
One of them asks about growth. Is the top line compounding, and does any of it survive the trip to the bottom? That question belongs to the income statement, to the history of growth rates and to the analyst forecasts. The other asks something blunter: does this firm reach its next filing without asking anyone for money? For that you need the balance sheet and the cash flow statement.
Two questions, two documents, and a ratio built for one of them cannot answer the other. Debt to assets knows nothing about whether the product sells. Operating margin knows nothing about the bond that matures in fourteen months.
That time is a condition, not an engine. A company can have it in abundance and stand perfectly still.
The safest company in the world is worth its cash
Picture a company that does nothing at all. No debt, no inventory, no staff, no product that can fail, no competitor with grounds to sue. There are 2 billion in the account and that is the whole of it.
This company scores maximum on every safety measure anyone has invented. It is also worth exactly 2 billion, because there is nothing there to turn into another dollar. Nobody pays a premium, since a premium is the price of future earnings and there are none.
That is the extreme, and it sets everything else. An armoured state limousine is solid, stable and beautifully built, and it will never break a speed record.
Neither will a car with no brakes, for a different reason: it does not finish. Which is why "ignore safety, growth is what counts" sounds wise right up to the first quarter with no sales, the first product recall and the first covenant test.
The other extreme bills you faster. A company that borrowed heavily to buy scale becomes sensitive to things that have nothing to do with its product: to dearer money, to one quiet quarter, to a defect that forces it to take a batch back and repair it at its own cost. With a thin cushion, each of those ends in a conversation with the bank, and a conversation with the bank in your worst quarter is the most expensive one a board ever has.
Why the correlation is not a cause
The popular argument is stronger than it looks, so it deserves an honest hearing. Companies with clean balance sheets do behave better than the broad market on average, and that is not an illusion. It shows up often enough that coincidence is a poor explanation. Anyone who built a rule out of it has an observation behind them, not a hunch.
The causal chain, though, runs alongside the balance sheet rather than through it. A firm whose finances are arranged sensibly usually has a sensible board, a sensible finance director and a product somebody wants. A clean balance sheet is a symptom of the same thing that produces the growth, not its source.
The distinction sounds academic until it costs money. It costs money when somebody buys a company for the absence of debt, the way they would buy it for a new contract. Having no debt is not a business achievement, it is a financing state measured by the ratio of debt to equity, read against the industry rather than against a fixed threshold, and one way to arrive at it is that nobody was willing to lend.
Where the balance sheet does select
That the balance sheet is a symptom does not mean it selects nothing.
There is replicated work in which the quality of the statements carries selection power, not just screening power. Joseph Piotroski, writing in the Journal of Accounting Research in 2000, showed that nine binary signals drawn from the balance sheet and the cash flows separate high book-to-market companies that go on to do better from those that do not. Robert Novy-Marx, writing in the Journal of Financial Economics in 2013, showed that gross profitability on its own carries information comparable to the classic book-to-price measure.
I quote no return figure from either paper, deliberately. Any such figure depends on the universe, the window and the costs, and a number copied out of somebody else's backtest is the most misleading kind of precision there is. The direction is enough, because the direction is what the conclusion rests on.
And the conclusion is more careful than the guidance on either side of this argument tends to be: fundamentals select more slowly than you would like, and the first thing they do is screen. The selection in that research works at portfolio scale over years, not in one decision about one company this week. Screening works immediately.
No debt is an option that never appears in assets
There is one route by which safety does turn into a result, and it runs through no table. A company with nothing pledged can borrow when money is expensive and its rivals cannot borrow at all. It can take over a weaker competitor, add capacity, or simply wait out a year in which the market buys nothing.
A company whose assets are already pledged has no such move, and it finds that out at the worst possible moment, because credit comes against collateral and the collateral is spoken for. Borrowing capacity is an asset with no line in assets, and it is the one place in this whole area where a safety buffer genuinely converts into future profit.
The direction still holds, though. That option pays in a crisis and not in a bull market, so buying a company for the absence of debt alone is buying insurance, not an engine.
Why fundamentals are the second read, not the first
Once screening outranks selection, the order in which you open documents stops being a matter of taste. Profitability first, because that is where the shortlist comes from. Fundamentals second, to check whether anyone on the list is a year away from running out of cash. Valuation last, which is the question of whether today's price is worth paying.
The boundary between the first step and the second is a gate, not a corridor. Weak profitability ends the work before anyone opens a balance sheet, and that saves tens of minutes per name. There is no point studying the debt of a company that was never going to make the portfolio, and the order in which the documents come out is part of the method rather than a convenience.
The second asymmetry matters more and gets said less often. The fundamental step has no authority to turn a decision into a yes. It can hold one or kill one, and that is the whole of its power. If a balance sheet can talk you into a company whose profitability you rejected an hour earlier, your profitability test was set for something other than what you think.
Reversing the order fails in a predictable way. You start at the balance sheet, find a firm with cash and no borrowings, and go looking for a reason it should grow. A reason always turns up, because every company has a story about a new market, and you go looking for it already fond of the answer. Read second, the same balance sheet produces no feeling at all, because then it only answers whether anything here can blow up.
How company financial health screens in practice
Start with the test that needs no formula and no ratio. Put current assets next to current liabilities: that is the answer for the next twelve months. Then non-current assets next to non-current liabilities: that is the answer past a year. Finally subtract every liability from every asset, and do the same on the two previous balance sheets.
Net worth does not have to grow. It must not slide into a trend, because a downward trend heading for zero says the business does not sustain itself at this size. Three years is the lower bound of meaning, and a balance sheet that has been through one recession says more than three years of good weather.
Only after that do I reach for ratios, and for several at once, because a single reading with no threshold behind it is trivia. The first of them asks how many times operating profit covers the interest bill, and what size of fall wipes that cushion out. The thresholds themselves, each with the question standing behind it, sit in the list of criteria you walk a single company through.
The one number with an author and a year
Most safety thresholds circulating online are somebody's calibration published without a name attached. There is one exception you can cite. Edward Altman, writing in the Journal of Finance in 1968, split companies into three zones: above 2.99 the safe zone, below 1.81 the distress zone, and the grey zone between them.
A zone is not a line. The difference between a reading of 1.79 and one of 1.81 does not exist, and a company just under the top of the grey band is often in better shape than one just above it with a single good quarter behind the number.
Run it yourself on round numbers. Say a company has assets of 8 billion and liabilities of 4.2 billion, working capital of 1.2 billion, retained earnings of 3.1 billion, operating profit of 900 million, revenue of 2.4 billion and a market value of 14 billion. The manufacturing variant weights five relationships:
- 1.2 × working capital to assets, so 1.2 × 0.15 = 0.18
- 1.4 × retained earnings to assets, so 1.4 × 0.39 = 0.54
- 3.3 × operating profit to assets, so 3.3 × 0.11 = 0.37
- 0.6 × market value to liabilities, so 0.6 × 3.33 = 2.00
- 1.0 × revenue to assets, so 1.0 × 0.30 = 0.30
The sum is 3.39, the safe zone with room to spare. It also shows where that result really came from. Close to sixty percent of it was contributed by the fourth line, the one holding the market value. Halve the share price and this same company drops into the grey band without a single change in the filing.
Which is why the variant matters. For non-manufacturers you use the version without asset turnover and with book value in place of market value, and its zones move to 2.60 and 1.10. A firm that designs its products and has somebody else build them, scored on a yardstick cut for factories, will always come out worse than it deserves.
What the balance sheet will not tell you
The first limit is the industry. Leasing, property and utilities stand on debt by construction, and a rigid debt threshold removes healthy companies from the list purely for financing themselves the way their industry finances itself. A bank is accounted for differently again, and the same rules reach it last.
The second limit is what the line marked "debt" leaves out. Leases, pension obligations, guarantees given for subsidiaries and contingent payments on acquisitions are all promises to pay, and they live in the notes, in the part of the report most readers never reach. Net debt worked out from the notes can come in well above the figure printed in a ready-made ratio table, and nobody will spot that gap for you.
The third limit is the one-off. A write-down after a failed acquisition, a negative result in the year of consolidation, or a change of fiscal year can wreck any composite score while the company is in better shape than it was a year earlier.
And the fourth limit is personal. "I give fundamentals no weight at all" can be perfectly true coming from someone with another source of income, a longer horizon and twenty years of reading companies. That is a decision taken by a person with a particular tolerance for risk, not a rule you can copy across with the rest of the method.
What to do with this in the next week
Take one company you hold and walk through four questions in this order:
- Do current assets cover current liabilities, and if not, where does the rest come from?
- Across three consecutive sheets, is net worth rising, flat or sliding?
- Is debt growing faster than assets, or more slowly?
- Does cash from operations service that debt without a new issue?
Four answers take half an hour and in most cases change nothing, because the company simply passes. That is not wasted time, it is the unit cost of screening. This kind of work pays for itself in the handful of cases where the answer is no and the rest of the market has not said so yet.
The hardest part of the job, I think, is not the arithmetic. It is holding back the conclusion. A company that cleared all four questions is not thereby better than one that cleared them last quarter and today carries two percentage points more margin.
At Taufolio this work sits in the Full report: the financial stability section lines up debt, coverage and liquidity across several years and leaves a link beside every number to the filing it came from. The finished report produces an Investment thesis, where the safety condition gets a measurable boundary, so three quarters from now you do not have to remember what worried you. What that looks like on a real company is in the example reports.
I do not know whether a firm with a good balance sheet survives a bad decade in its industry, because the market it stands on answers that, not a table of liabilities. I do know that a firm with a bad balance sheet does not survive one bad year, and bad years arrive more often than memory suggests.
And if you have time for one question instead of four, make it this one: what would have to happen for this company to join the queue for capital in the worst possible quarter?
Well-run balance sheets answer that briefly.
Frequently asked questions
Does good company financial health lead to a higher share price?
How do you assess a company's financial health in five minutes?
What is the difference between fundamental analysis and profitability analysis?
Is low debt on its own a reason to buy a stock?
What is the Altman score and how should the result be read?
- fundamentals
- financial-statements
- research
Posts are produced with AI tools and go through editorial review by the Taufolio team before publishing. How we write and correct posts